Broken cell preparations of rat and human placentas contain an inner (tyrosyl)-ring iodothyronine deiodinase enzyme with greatest activity when the substrate is 3,5,3'-triiodothyronine (T3). This report describes the deiodination of T3 in the intact placenta and the effect of sodium iopanoate (IA) and propylthiouracil (PTU) on T3 deiodination. Under nembutal anesthesia, the placenta of60-65-d-old pregnant guinea pigs was surgically exposed, a single umbilical artery and the umbilical vein were cannulated, and the fetus was removed. In a temperature-controlled chamber (37°C), the fetal side of the placenta was perfused through the umbilical artery at a rate of 1 ml/min with 3% bovine serum albumin Krebs-Henseleit buffer containing 0.14 nM outer ring labeled 1'"IJT3. Placenta effluent fractions were collected at timed intervals from the umbilical vein canulla throughout a 120-min perfusion period. The contents of the perfusion buffer and the various effluent fractions were analyzed for their iodothyronine content by high pressure liquid chromatography. In five experiments, the percent composition of '25I-labeled iodothyronines in the perfusion buffer and placenta effluent was 95.3±1.0 (mean±SE) and 70.2±2.1 for T3 (P < 0.01), 2.5±0.7 and 20.1±1.8 for 3,3'-T2 (P < 0.01), and 0 and 8.2±0.9 for 3'-Ti. The placenta receives a large percentage of the fetal cardiac output (1), and, as we and others have reported (2-7), contains enzymes that deiodinate thyroid hormones. These observations support the possibility that the placenta is an important site for fetal thyroid hormone metabolism. Deiodination of the iodothyronines can occur in the phenolic (5' or outer) or in the tyrosyl (5 or inner) rings. These deiodinative pathways play a major role in the metabolism of thyroxine (T4),' generating the metabolically active iodothyronine, 3,5,3'-triiodothyronine (T3), and the metabolically inactive iodothyronine, 3,3',5'-triiodothyronine (rT3). Deiodination is also the principal pathway for the metabolism of T3, which results in the formation of the inactive diiodothyronines, 3,3'-T2 and 3,5-T2, as well as the inactive monoiodothyronines, 3'-T, and 3-T1. Thus, placental deiodination is potentially an important mechanism for the modulation of fetal thyroid hormone action. While detailed studies of deiodination have been performed in placenta homogenates and subcellular fractions (6, 8) , there is little information on iodothyronine deiodination in the intact placenta (9).
Introduction
Broken cell preparations of rat and human placentas contain an inner (tyrosyl)-ring iodothyronine deiodinase enzyme with greatest activity when the substrate is 3,5,3'-triiodothyronine (T3). This report describes the deiodination of T3 in the intact placenta and the effect of sodium iopanoate (IA) and propylthiouracil (PTU) on T3 deiodination. Under nembutal anesthesia, the placenta of60-65-d-old pregnant guinea pigs was surgically exposed, a single umbilical artery and the umbilical vein were cannulated, and the fetus was removed. In a temperature-controlled chamber (37°C), the fetal side of the placenta was perfused through the umbilical artery at a rate of 1 ml/min with 3% bovine serum albumin Krebs-Henseleit buffer containing 0.14 nM outer ring labeled 1'"IJT3. Placenta effluent fractions were collected at timed intervals from the umbilical vein canulla throughout a 120-min perfusion period. The contents of the perfusion buffer and the various effluent fractions were analyzed for their iodothyronine content by high pressure liquid chromatography. In five experiments, the percent composition of '25I-labeled iodothyronines in the perfusion buffer and placenta effluent was 95.3±1.0 (mean±SE) and 70.2±2.1 for T3 (P < 0.01), 2.5±0.7 and 20.1±1.8 for 3,3'-T2 (P < 0.01), and 0 and 8.2±0.9 for 3'-Ti. There was no difference between the percent 1125I]iodide in the perfusion buffer and in the placenta effluents. When placentas were perfused with IA and 112511T3, after perfusion with 1125IJT3 alone, there was a significant increase (P < 0.01) in the percent 1125Jlr3 in the placenta effluents, and a significant decrease in ['25I]3,3'-T2 (P < 0.01) and 125 113'-T, (P < 0.01). In contrast, PTU did not affect the composition of labeled iodothyronines in the placenta effluents, despite the fact that the addition of PTU significantly (P < 0.001) inhibits the inner-ring deiodination of 1125IT3 in human or guinea pig placenta microsomes in the presence of low (0.25 mM) concentrations of dithiothreitol. The present studies demonstrate that T3 is actively deiodinated in the inner ring to 3,3'-T2 by the intact guinea pig placenta. A portion of 3,3'-T2 is further deiodinated in the inner ring to generate 3'-TI. No outer ring deiodination of T3 was seen under the conditions employed. IA, but not PTU, inhibits T3 deiodination in the placenta perfused in situ. We conclude that the placenta is probably a site for fetal T3 metabolism.
The placenta receives a large percentage of the fetal cardiac output (1) , and, as we and others have reported (2-7), contains enzymes that deiodinate thyroid hormones. These observations support the possibility that the placenta is an important site for fetal thyroid hormone metabolism. Deiodination of the iodothyronines can occur in the phenolic (5' or outer) or in the tyrosyl (5 or inner) rings. These deiodinative pathways play a major role in the metabolism of thyroxine (T4),' generating the metabolically active iodothyronine, 3,5,3'-triiodothyronine (T3), and the metabolically inactive iodothyronine, 3,3',5'-triiodothyronine (rT3). Deiodination is also the principal pathway for the metabolism of T3, which results in the formation of the inactive diiodothyronines, 3,3'-T2 and 3,5-T2, as well as the inactive monoiodothyronines, 3'-T, and 3-T1. Thus, placental deiodination is potentially an important mechanism for the modulation of fetal thyroid hormone action. While detailed studies of deiodination have been performed in placenta homogenates and subcellular fractions (6, 8) , there is little information on iodothyronine deiodination in the intact placenta (9) .
In this study, we discovered the metabolic fate of T3 when perfused through the fetal side ofthe guinea pig placenta in situ. Since previous studies employing placenta homogenates have shown an inhibitory effect ofpropylthiouracil (PTU) and sodium iopanoate (IA) on T4 deiodination (8) , the effect of these drugs on T3 metabolism in the intact placenta was evaluated. further injections of 5-10 mg nembutal were administered during the perfusion. After induction of anesthesia, a laparotomy was performed and a single fetus was exposed through a small uterine incision. Both uterus and placenta were left within the maternal abdominal cavity to minimize hemodynamic changes in the maternal circulation to the placenta. The fetal umbilical arteries and vein were cleared of fetal membranes. To facilitate cannulation, we caused the dilation of vessels by the topical application of 4% papavarin. The umbilical vein and one fetal artery were cannulated with PE60 polyethylyne tubing with an internal diameter of 0.03 in and external diameter of 0.048 in. The remaining vessels leading to the fetus were tied off and the fetus was removed. The fetal side of the placenta was then perfused at a rate of 1.0 ml/min through the umbilical artery from a reservoir containing 3% bovine serum albumin (BSA) in Krebs-Henseleit (KH) buffer (0.1 10 M NaCl, 2.4 mM CaCl2, 4.4 mM KCl, 1.1 mM KH2PO4, 1.1 mM MgSO4' 7H20, and 25.0 mM NaHCO3, pH 7.4). Placental pressure was monitored with a string-gauge transducer and catheter positions were adjusted to maintain a placental pressure between 20-40 mmHg. The uterine opening was covered with gauze that had been soaked in 0.9% saline to keep the cannulated placental vessels moist.
Methods
Experimental procedure. A 20-min preperfusion ofthe placenta with KH buffer was performed before the start of each experiment to ensure stabilization of the placenta. During the preperfusion as well as during the experimental period, the dam and the perfusion reservoir were kept in a plexiglass chamber thermostatically maintained at 37°C. During the experimental period, ['25I]T3 was added to the perfusion reservoir to obtain a concentration of0. 104 to 0.121 gCi/ml. Depending on its specific activity, the total T3 concentration in the perfusion buffer ranged from 0.08 to 0.14 nM. The percent-free T3 in the perfusion buffer was 0.4±0.01% (mean±SE) determined by equilibrium dialysis as previously described in our laboratory (1 1). Thus, the free [1251I]T3 that perfused the placenta ranged from 0.32 to 0.56 pM. The placenta effluent samples were then collected at timed intervals and the iodothyronine content of the perfusion buffer and placenta effluent samples was analyzed by high pressure liquid chromatography (HPLC) (see below).
In five experiments, the placenta was perfused with ['25I]T3 alone for 120 min. In other experiments, placentas were perfused with ['lI]T3 alone for 40 min. At 40 min, the perfusion buffer was changed to one that contained 251I-T3 and a substance to be tested for inhibition of placenta inner ring deiodinase activity; this perfusion was continued for another 40 min. The pH of the perfusion buffer did not change when any of the test substances were added to the perfusion buffer. Finally, for the remaining 40-min period the placenta was perfused with ['12I]T3 alone. Thus, in experiments in which a putative inhibitor was tested, the 40-min perfusion of the test substance was preceded and followed by 40-min periods during which ['"l]T3 alone was perfused. Placenta effluent fractions were collected and analyzed for iodothyronine content during the last 20 min of the three 40-min perfusion periods. In our perfusion system, 20 min elapsed before steady-state conditions were observed in placenta effluent samples after the onset of perfusion. Similarly, a 20-min "wash-out" elapsed before effluent content reached background levels after discontinuation of perfusion. Thus, the sampling times employed ensured that samples were not taken during times in which the perfusion conditions were changing.
Analysis of samples. Placenta effluent samples and perfusates were analyzed for iodothyronine content by HPLC. Aliquots (2 ml) of effluent and perfusate samples were lyophilized and iodothyronines were extracted from the lyophilized material with 2.5 ml of 1% NH40H in methanol. Samples were then centrifuged at 3,000 rpm and the supernatants were decanted and dried under an air stream. The dried samples were reconstituted in 0.5 ml HPLC mobile phase (48% MeOH, 52% 49 mM NaH2P04, and 25 mM H3PO4). In this extraction procedure, the recovery of T3 relative to the recovery of 3,3'-T2 was 92%, and the recovery of 3'-T, relative to the recovery of 3,3'-T2 was 106%. The final calculations did not take into account these small differences in relative recovery. Aliquots of the samples containing between 35,000 and 50,000 cpm were subjected to HPLC using a C18 microbondapak column (Millipore/ Waters Chromatography, Milford, MA). Samples were injected, in the presence ofHPLC mobile phase, containing 30 ,g of nonradioactive T3, 3,3'-T2, and 3'-T, markers. lodothyronines were separated and eluted at an operating pressure of 2,600 p.s.i. and a flow rate of 1.7 ml/min. The iodothyronine markers were detected at a wavelength of 254 nm and were used as reference points for 1251 radioactivity eluting from the column. Table I shows the retention times for ['25Iliodide and stable 3'-TI, 3 ,3'-T2, 3',5'-T2, 3,5-T2, T3, and T4. HPLC eluate fractions were collected every 0.6 min and counted in a gamma counter.
Effect ofPTU on T3 deiodination in placenta microsomes. We previously showed that in the presence of suboptimal dithiothreitol (DTT) concentrations PTU inhibits the inner-ring deiodination ofT4 in human placenta microsomes (8) . When DTT concentrations were optimal, no inhibition of inner ring deiodination was observed. Since T4 rather than T3 was employed as the substrate for these studies (8), we considered it important to confirm that PTU, in the presence of low DTT concentrations, also inhibits T3 deiodination by placenta microsomes. For these studies, human and guinea pig microsomes were prepared as previously described (8) Guinea pig microsomal protein was present in a concentration of 1.8 mg/ml and human microsomal protein was present in a concentration of 0.9 mg/ml. Incubations were performed at 37°C for 30 min and terminated by the addition of 2 vol of 95% ethanol per incubation tube. The incubation products were analyzed and quantitated by paper chromatography in a hexane/tertiary amyl alcohol/2 N ammonium hydroxide (1:5:6) solvent system as previously described (5 3,3'-T2. As compared to the percent iodothyronines in the perfusion buffer, the mean composition of labeled iodothyronines in the placenta effluent samples for all time periods was 70.2±2.1% T3 (P < 0.01), 20.1±1.8% 3,3'-T2 (P < 0.01), and 8.2±0.9% 3'-Tj (P < 0.01). In these five experiments, 84±8.8% of the total amount of radioactivity that perfused the placenta was recovered in the placenta effluent samples. Some radioactivity (3,000 cpm/ml or less) could be identified in maternal serum at the end of the perfusions. However, this amount of radioactivity was insufficient for analysis of the labeled substances. Some radioactivity also appears to be withheld within placental tissue or placental microcirculation, given that the radioactivity in placenta effluents logarithmically decreases to background levels during the first 20 min after discontinuation of perfusion with [ 
Discussion
The rat and human placenta contain relatively large amounts of an iodothyronine tyrosyl deiodinase enzyme (4, 5, 7) . The enzyme has been localized to the microsomal fraction ofplacenta homogenates and has an absolute requirement for sulfhydryl reducing agents regardless of the purity of the preparation (8).
Microsomal preparations ofplacenta tyrosyl ring deiodinase are inhibited by various pharmacological agents, including IA and PTU (8) . However, there are no reports on the effects of these agents on iodothyronine tyrosyl deiodinase in the intact placenta in vivo. In fact, information on iodothyronine metabolism in the intact placenta is limited. Cooper et al. (9) have studied the metabolism of labeled T4 and rT3, but not T3, in the perfused guinea pig placenta. They observed no tyrosyl ring deiodination of rT3 when rT3 was perfused into the fetal side of the placenta, but did note tyrosyl ring deiodination of T4 when this iodothyronine was perfused. However, the magnitude of T4 tyrosyl ring deiodination was very small, being <0.4% in a single pass through the placenta. To determine the nature and magnitude of T3 deiodination in the intact placenta and the influence of IA and PTU, we employed a guinea pig perfusion system adapted from the method of Kihlstrom and Kihlstrom (10). It was identical in terms ofperfusion buffer, flow rate, perfusion pressure, albumin concentration, and temperature, and it used a thermostatically controlled chamber to maintain constant temperature (10). This system has been used in many previous studies ofplacenta physiology (12) ; it is ideal for studies of species with hemochorial placentation, as in, for example, man and rodents. Although most published studies on placental deiodination have been performed with rat and human homogenates, the use ofthese species for perfusion of the intact placenta presents certain limitations. The umbilical vessels of the rat are too small to cannulate and the perfusion models for the human placenta are less physiological because, unlike the guinea pig perfusion system, the maternal relationships to the placenta are disrupted.
The ['"I]T3 used in these studies was labeled in the 3'-position. Therefore, the labeled products of T3 inner-ring deiodination are [ (9) also did not observe outer-ring deiodination ofT4 or rT3 when these compounds were perfused through the fetal side of the placenta. This is in contrast to the recent report of Kaplan and Shaw (6) that rat and human placenta contains an outer-ring deiodinase when either T4 or rT3 were employed as substrates. In their study, outer-ring deiodinase activity could only be detected at low substrate concentrations, which consisted of 2 nM in the case of rT3 or 0.15 nM in the case of T4. They did not report results using T3 as substrate. It is possible that the failure of Cooper et al. (9) to observe outerring deiodination ofT4 in the intact placenta was due to the fact that they employed higher T4 substrate concentrations of 46 nM. However, no outer-ring deiodinase activity was noted when rT3 was perfused in tracer concentrations (specific activity was not specified). Kaplan and Shaw (6) also noted that the activity of outer-ring deiodinase in the placenta was greatest in the zone immediately adjacent to the uterine wall. Therefore, iodothyronines that circulate in the fetal side of the placenta may have limited access to the outer-ring deiodinase enzyme described by Kaplan and Shaw (6).
Although we could not detect outer-ring deiodination of T3 in the perfused placenta, tyrosyl or inner-ring deiodination of T3 was clearly demonstrated under conditions in which 0.14 nM T3 was perfused. Approximately 27% of the T3 was deiodinated to 3,3'-T2 and 3'-T, in a single pass through the placenta. When 140 nM T3 was perfused, the fractional conversion of T3 to 3,3'-T2 and 3'-T, was 15%. These results for T3 are much higher than the fractional conversion rate of 0.4% observed by Cooper et al. (9) when T4 was perfused at a concentration of 46 nM, and are compatible with our previous observations that T3 is the preferred substrate for the inner-ring deiodinase enzymes in rat and human placentas (4, 5) . In contrast to Cooper et al.'s study, the [125I]-T3 concentration employed in our study approximated serum T3 concentrations in the term fetal guinea pig. Total serum T3 levels at term at 0.4±0.03 nM and free T3 levels are 1.64±0.13 pM (mean±SD, n = 6) (13). Thus, our results indicate that the guinea pig placenta is capable of substantial T3 metabolism at physiologic concentrations. The rapid rate of T3 deiodination by the placenta may provide a partial explanation for the observation that severance of the umbilical cord is associated with an increase in plasma T3 concentration at the time of delivery (14). Since the plasma concentration of a hormone is equal to its production rate divided by its metabolic clearance rate (15) , cutting the umbilical cord would likely have an important impact in decreasing the metabolic clearance rate of T3 by eliminating a major and rapid site for T3 deiodination. This, in turn, would result in an increased plasma T3 concentration. In fact, metabolic clearance rates of T3 have been shown to be much higher in fetal sheep than in adults (16, 17) . The ratio of T3 production in the fetal circulation as compared with the maternal circulation is not precisely known due to lack of sensitivity of the methods (16, 17 T3, because of its rapid deiodination, is an ideal substrate for the study of acute drug effects under conditions similar to those obtained in vivo. The present study shows that IA has a rapid and reversible inhibitory effect on iodothyronine innerring deiodinase in the intact placenta. We have previously reported that PTU inhibits the tyrosyl-ring deiodination of T4 by human and rat placenta homogenates and microsomes when incubations are carried out in the presence of low DTT concentrations, but not when DTT is present in concentrations that are optimal for enzyme activity. As shown in the present study, PTU also inhibits T3 tyrosyl-ring deiodination in human and guinea pig microsomes incubated in the presence of low DTT concentrations. The observation that PTU does not inhibit T3 tyrosyl ring deiodinase activity in the in situ perfused placenta suggests that, under in vivo conditions, the placenta may have a relatively abundant supply of endogenous cofactors required for T3 deiodination. It is also possible that intracellular concentrations of PTU in vivo were too low to produce enzyme inhibition. However, since PTU crosses the placenta (18) , it seems likely that some PTU does enter the thin layer of trophoblastic cells that separates the fetal and maternal circulations.
Obviously, the perfused guinea pig placenta is of limited use for detailed kinetic studies of deiodination, studies that involve comparison ofmultiple perturbations, or those that require prolonged longitudinal observations. These limitations are due to the fact that, ideally, all observations must be made within a relatively short period oftime. However, the present studies show that information can be obtained that is in many ways more physiologically and clinically relevant than that obtained in disrupted cell and organ preparations or in cultured cells. PTU is administered to pregnant women with hyperthyroidism and is known to traverse the placenta and to reach the fetal circulation (18) . IA is generally not administered to pregnant women, but recent studies have suggested that this class of compounds may be useful in treating Graves' Disease (19) . It is possible that the administration of IA-but not PTU-to pregnant women could affect placental tyrosyl deiodination of T3, although the extent of this effect and its clinical relevance remains unclear. Further studies on the effects of maternally administered IA and PTU on placenta inner-ring deiodinase activity may yield information on this point.
In summary, the present study demonstrates that T3 is very actively deiodinated in the tyrosyl ring by the intact guinea pig placenta. It suggests that the placenta is a major site ofT3 disposal in the fetus. Therefore, the activity of the placenta deiodinase may influence fetal serum T3 concentrations. Despite the fact that PTU inhibits inner-ring deiodinase in placenta homogenates, the present studies suggest that PTU may not affect inner-ring deiodinase in the intact placenta. Therefore, it is possible that its use in pregnant women may not be associated with impaired placental deiodination of fetal T3. Iopanoate and related compounds, however, are likely to impair placental tyrosyl ring deiodination of the iodothyronines and affect fetal thyroid hormone metabolism.
